STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
SUTRO BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$11.26+0.32 (+2.88%)
Close on Oct 19, 2026
- Market cap
- $186.51M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Sutro Biopharma has not reported a dividend
No dividend per share appears in Sutro Biopharma's annual filings since fiscal 2015.